Clinical Effectiveness of Non-contact Heart Rate and Respiratory Rate Monitoring System

NCT06573203 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-03-05

No results posted yet for this study

Summary

In this study, hospitalized neonates were taken as the focus of the study. The non-contact heart rate and respiratory rate monitoring system was used to measure heart rate, respiratory rate, sleep parameters, ECG monitor, neonatal sleep-wake scale, amplitude-integrated electroencephalography. aEEG), in order to provide a theoretical basis for standardizing the operation of medical staff and formulating sleep protection strategies in the future, so as to promote the sleep quality of hospitalized neonates and improve the prognosis of neonates.

Conditions

  • Sleep
  • Infant,newborn
  • Vital Signs

Interventions

DEVICE

Non-contact heart rate and respiratory rate monitoring system

Each neonate enrolled underwent four sleep and vital signs monitoring procedures after admission.

DEVICE

Mindray ECG monitor

Heart rate and respiratory rate of each enrolled child were monitored after admission.

DEVICE

aEEG

Each enrolled child underwent a 6-hour sleep-wake cycle, quiet sleep, and active sleep monitoring after admission.

OTHER

Neonatal Sleep-Wake Assessment Tool (NSWAT) included four dimensions: eye movement, respiratory rate, facial expression and muscle activity.

The study nurses observed and scored the children's sleep-wake status 10 minutes after two meals during the mattress test period, each time for 5 minutes.

Sponsors & Collaborators

  • Jiaxing Yuanbeibei Technology Co. LTD

    collaborator UNKNOWN
  • Children's Hospital, Zhejiang University School of Medicine

    collaborator UNKNOWN
  • The Children's Hospital of Zhejiang University School of Medicine

    lead OTHER

Principal Investigators

  • Hongzhen Xu · The Children's Hospital Affiliated to the Medical College of Zhejiang University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-21
Primary Completion
2026-08-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06573203 on ClinicalTrials.gov